GlassScriptPhysician profile
Prashant Pramod Parikh
NPI 1881612893
$5,374.11
in general payments reported to CMS, 2019-2025
30 companies · $1,258 in 2025
The $1,258 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,632 · 2020: $322 · 2021: $24.55 · 2022: $32.89 · 2023: $871 · 2024: $1,233 · 2025: $1,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,362.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $832.61 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $589.43 | 2019-2025 | Evenity, Repatha, Otezla |
| Glaxosmithkline, LLC. | $567.02 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $554.70 | 2019-2025 | |
| Novo Nordisk INC | $453.77 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $435.25 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Merck Sharp & Dohme LLC | $333.58 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Abbvie INC. | $234.02 | 2019-2025 | |
| Exact Sciences Corporation | $207.57 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $176.97 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $155.08 | 2019-2024 | |
| Abbott Laboratories | $122.43 | 2023-2025 | Freestyle Libre 3, Esprit, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.66 | 2019-2023 | Jardiance |
| Allergan, INC. | $78.92 | 2019 | |
| Daiichi Sankyo INC. | $72.15 | 2020-2025 | Injectafer |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $60.46 | 2023-2024 | |
| Amarin Pharma, INC. | $51.37 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $45.77 | 2023-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Sanofi-Aventis U.S. LLC | $41.03 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $39.00 | 2019-2025 | Zoryve |
| Arteriocyte Medical Systems, INC. | $30.10 | 2019 | |
| Watermark Medical, INC. | $28.48 | 2024 | |
| Hologic Sales and Service, LLC | $23.16 | 2025 | Aptima |
| Seqirus USA INC | $21.56 | 2024 | Fluad, Flucelvax |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.10 | 2023 | Cycloset |
| Masimo Corporation | $20.28 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.42 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.17 | 2024 | Nuzyra |
| Sanofi Pasteur INC. | $14.76 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashant Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.